Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2020-11-10 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
201110 - Disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposals of own shares" and details transactions where the company disposed of UCB shares OTC following the exercise of stock options by personnel under the Long Term Incentive Program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities by the company itself. The document is short and appears to be a regulatory disclosure of these specific transactions.
2020-11-10 English
201110 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA sold (aliéné) its own shares following the exercise of options by employees as part of long-term variable remuneration. This directly corresponds to the definition of a company reporting transactions involving its own shares, specifically share repurchase/issuance, which maps to the 'Transaction in Own Shares' category. The filing type code is POS (Transaction in Own Shares). The document is a formal announcement dated November 10, 2020, providing specific transaction details, which confirms it is a primary filing, not just an announcement of a report (RPA/RNS).
2020-11-10 French
201110 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB NV disposed of its own shares following the exercise of options by employees under long-term incentive plans. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing is dated November 10, 2020, and is classified as 'gereglementeerde informatie' (regulated information), which supports a formal disclosure. The code POS matches this activity.
2020-11-10 Dutch
201030 - Disposals of own shares.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details 'Disposals of own shares' conducted by UCB SA/NV following the exercise of stock options under its Long Term Incentive Program. This activity involves the company transacting its own stock, which directly corresponds to the definition of 'Transaction in Own Shares'. The filing is a formal announcement dated October 30, 2020, providing specific transaction dates, quantities, and prices. This matches the definition for Code: POS (Transaction in Own Shares). The document length is short (1976 chars), but it contains the core data rather than just announcing another report, so POS is preferred over RPA/RNS.
2020-10-30 English
201030 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA sold shares from its treasury stock (aliéné des actions UCB hors bourse) following the exercise of options by employees as part of long-term variable remuneration. This directly corresponds to the definition of a company reporting transactions involving its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal announcement dated October 30, 2020, providing specific transaction dates, quantities, and prices.
2020-10-30 French
201030 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV transferred shares to employees under long-term incentive plans (Stock Option Plans) on specific dates in October 2020. This directly relates to the company buying back or issuing its own shares, specifically in the context of employee stock options being exercised and shares being delivered. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure of these specific transactions, not an announcement of a larger report.
2020-10-30 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.